The Phase 3 Keynote-181 Study: Pembrolizumab Versus Chemotherapy as Second-Line Therapy for Advanced Esophageal Cancer

AuthID
 P-00Q-VVQ
20
Author(s)
Francois, E
·
Shah, M
·
Adenis, A
·
Enzinger, P
·
Kojima, T
·
Muro, K
·
Bennouna, J
·
Hsu, C
·
Moriwaki, T
·
Kim, S
·
Lee, S
·
Kato, K
·
Shen, L
·
Qin, S
·
Ferreira, P
·
Wang, R
·
Bhagia, P
·
Kang, S
·
Doi, T
Tipo de Documento
Abstract
Year published
2019
Publicado
in ANNALS OF ONCOLOGY, ISSN: 0923-7534
Volume: 30
Conference
European-Society-For-Medical-Oncology (Esmo) 21St World Congress on Gastrointestinal Cancer, Date: JUL 03-06, 2019, Location: Barcelona, SPAIN, Patrocinadores: European Soc Med Oncol
Indexing
Wos®
Publication Identifiers
Wos: WOS:000475860200011
Source Identifiers
ISSN: 0923-7534
Export Publication Metadata
Lista Marked
 Adicionar à lista Marked
Info
At this moment we don't have any links to full text documens.

Um espaço para investigadores e suas Instituições

Links Úteis

Ajuda

© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service